| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/10/2007 | US20070104783 Double-Layered Absorbable Solid Compositions for the Topical Treatment of Oral Mucosal Disorders |
| 05/10/2007 | US20070104782 Modified release tablet formulations with enhanced mechanical properties |
| 05/10/2007 | US20070104781 Hypocholesteremic preparations containing mixtures of phytostenol(ester)s and conjugated fatty acids, and methods of using the same |
| 05/10/2007 | US20070104780 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/10/2007 | US20070104779 Treatment with omega-3 fatty acids and products thereof |
| 05/10/2007 | US20070104778 Controlled-release emulsion compositions |
| 05/10/2007 | US20070104777 Targeted liposomal drug delivery system |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104775 Amphoteric liposomes |
| 05/10/2007 | US20070104774 Method for preparing phytosphingosine liposome composition |
| 05/10/2007 | US20070104773 Skin application medicament, method of applying the same to skin, and method of manufacturing the same |
| 05/10/2007 | US20070104772 Amorolfine patch for the treatment of onychomycosis |
| 05/10/2007 | US20070104771 Transdermal galantamine delivery system |
| 05/10/2007 | US20070104770 Methods and Compositions For Topical Wound Treatment |
| 05/10/2007 | US20070104768 Devices for the delivery of molecular sieve materials for the formation of blood clots |
| 05/10/2007 | US20070104767 Compositions and methods for improving integrity of compromised body passageways and cavities |
| 05/10/2007 | US20070104766 Elastomeric article with antimicrobial coating |
| 05/10/2007 | US20070104763 Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making |
| 05/10/2007 | US20070104759 Sustained release inserts; mixture of thermoplastic polyester, solvent and leuprolide acetate; prostate cancer |
| 05/10/2007 | US20070104754 gastric device having a pouch formed from a gas producing degradable film; gastric devices occupy space in the stomach cavity and reduce the amount of food the patient will ingest before reaching the feeling of fullness; can reside in the stomach for a controlled and prolonged period of time |
| 05/10/2007 | US20070104745 Aqueous dispersions of crystalline polymers and uses |
| 05/10/2007 | US20070104744 Ophthalmic and contact lens solutions containing forms of vitamin b |
| 05/10/2007 | US20070104743 Formulations of fispemifene |
| 05/10/2007 | US20070104742 Novel oral formulations of ospemifene |
| 05/10/2007 | US20070104741 Delivery of tetrahydrocannabinol |
| 05/10/2007 | US20070104740 Self-microemulsifying drug delivery systems of a hiv protease inhibitor |
| 05/10/2007 | US20070104709 Non-naturally occurring ligand for umami taste and sweet taste receptor; enhancing response to artificial flavoring |
| 05/10/2007 | US20070104701 Method for stabilizing reduced coenzyme Q10 |
| 05/10/2007 | US20070104688 Small interfering RNA mediated transcriptional gene silencing in mammalian cells |
| 05/10/2007 | US20070104684 Ocular gene therapy |
| 05/10/2007 | US20070104674 Aminofunctional silicone resins and emulsions containing them |
| 05/10/2007 | US20070104659 Capsule-containing oral composition |
| 05/10/2007 | US20070104658 Preparing spray-dried particles having a tap density of less than about 0.4 g/cm3 and have a hydrophobic amino acid and a therapeutic, prophylactic or diagnostic agent; pulmonary delivery; respiratory disorders |
| 05/10/2007 | US20070104657 Made by creating hollow, spherical drug particles (i.e., progenitor particles) that collapse in the process of particle formation, leading to wrinkled, thin-walled drug particles of very low envelope density; spray drying |
| 05/10/2007 | US20070104656 Matrices Formed of Polymer and Hydrophobic Compounds For Use in Drug Delivery |
| 05/10/2007 | US20070104655 Inhalers used in the treatment of respiratory system disorders, such as chronic obstructive pulmonary disease and asthma |
| 05/10/2007 | US20070104654 For delivery of water insoluble drugs, growth factors, genes, or cosmetic substances; biocompatible and biodegradable |
| 05/10/2007 | US20070104653 Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
| 05/10/2007 | US20070104652 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin |
| 05/10/2007 | US20070104651 comprises a sclerosant liquid, e.g. polidocanol solution, and a gas e.g. O2 or CO2; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins and other disorders involving venous malformation |
| 05/10/2007 | DE202006018608U1 Buprenorphin-Wafer zur Drogensubstitutionstherapie Buprenorphine wafer for drug substitution therapy |
| 05/10/2007 | DE19681207B4 Therapeutische Verwendung von Rubidiumionen und Zubereitungen Therapeutic Use of rubidium and preparations |
| 05/10/2007 | DE112005001560T5 Bodenklappenverschluß Bottom flap closure |
| 05/10/2007 | DE102005053862A1 Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel Method and apparatus for producing very fine particles and to coat such particles |
| 05/10/2007 | DE102005053011A1 Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis |
| 05/10/2007 | CA2784168A1 Growth control of oral and superficial microorganisms using gallium compounds |
| 05/10/2007 | CA2628562A1 Method and device for producing very fine particles and coating such particles |
| 05/10/2007 | CA2628462A1 A method for preparing a textile material and a textile material thus prepared and produced |
| 05/10/2007 | CA2628300A1 Modified sirna molecules and uses thereof |
| 05/10/2007 | CA2628226A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 05/10/2007 | CA2628207A1 Films and capsules made from modified carboxymethycellulose materials and methods of making same |
| 05/10/2007 | CA2628176A1 Process for the preparation of sterile powdered pharmaceutical compounds |
| 05/10/2007 | CA2627951A1 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 05/10/2007 | CA2627948A1 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 05/10/2007 | CA2627934A1 Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage |
| 05/10/2007 | CA2627584A1 Multi-layered coating technology for taste masking |
| 05/10/2007 | CA2627504A1 Sealed tablet |
| 05/10/2007 | CA2626586A1 Stable composition for a pharmaceutical formulation containing olanzapine |
| 05/10/2007 | CA2626585A1 A pharmaceutical formulation containing olanzapine |
| 05/10/2007 | CA2625096A1 Formulations comprising jorumycin-, reni eramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 05/10/2007 | CA2618799A1 Aqueous anaesthetic compositions comprising propofol |
| 05/10/2007 | CA2618026A1 Intravenous propofol emulsion compositions having preservative efficacy |
| 05/10/2007 | CA2610480A1 Nanoparticulate acetaminophen formulations |
| 05/09/2007 | EP1783113A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 05/09/2007 | EP1782839A1 Sterilization process of Glucocorticosteroid by supercritical CO2 |
| 05/09/2007 | EP1782824A2 Diaminooxidase-containing pharmaceutical preparations |
| 05/09/2007 | EP1782816A1 Water-based medicinal composition containing azithromycin and method of preparing the same |
| 05/09/2007 | EP1782807A1 Jelly composition |
| 05/09/2007 | EP1782803A1 Coenzyme q10-containing composition |
| 05/09/2007 | EP1782801A1 Eyewash liquid for dry eye therapy |
| 05/09/2007 | EP1782799A2 Transdermal therapeutic system comprising an active analogue of fentanyl |
| 05/09/2007 | EP1782798A2 Ascending-dose dosage form |
| 05/09/2007 | EP1782797A1 Process for the preparation of sterile powdered pharmaceutical compounds. |
| 05/09/2007 | EP1782796A1 Carrier for migration into cerebral neuron containing metal colloid particle |
| 05/09/2007 | EP1782795A1 Ophthalmic gel made up of triamcinolone acetonide and a polyacrylic polymer |
| 05/09/2007 | EP1782794A2 Anhydrous composition containing an acid-acid buffer system |
| 05/09/2007 | EP1782310A2 Method for measuring the incidence of hospital acquired infections |
| 05/09/2007 | EP1781593A2 Cationic lipids and methods of use |
| 05/09/2007 | EP1781336A2 Novel hydrogels and uses thereof |
| 05/09/2007 | EP1781334A2 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 05/09/2007 | EP1781333A2 Compositions and methods for nutrition supplementation |
| 05/09/2007 | EP1781319A2 Method for enhancing bone formation |
| 05/09/2007 | EP1781295A1 Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 05/09/2007 | EP1781292A1 Extended release formulation of 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-one |
| 05/09/2007 | EP1781275A1 Sustained release pharmaceutical composition of tolterodine |
| 05/09/2007 | EP1781266A2 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 05/09/2007 | EP1781265A2 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 05/09/2007 | EP1781264A2 Methods for manufacturing delivery devices and devices thereof |
| 05/09/2007 | EP1781263A2 Medicament in a multilayer form |
| 05/09/2007 | EP1781262A1 Pharmaceutical multilayer tablet for controlled_release of active ingredients with highly ph-dependent solubility |
| 05/09/2007 | EP1781261A1 Modified release formulation of memantine |
| 05/09/2007 | EP1781260A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 05/09/2007 | EP1781259A2 Improved stearate composition and method of production thereof |
| 05/09/2007 | EP1781258A1 Formulations of bisphosphonates |
| 05/09/2007 | EP1781257A2 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| 05/09/2007 | EP1781256A1 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 05/09/2007 | EP1781255A1 Compositions and methods for treating leukemia |
| 05/09/2007 | EP1781254A2 Pulmonary delivery of inhibitors of phosphodiesterase type 5 |
| 05/09/2007 | EP1781253A1 Preparation of pharmaceutical compositions containing nanoparticles |
| 05/09/2007 | EP1781252A2 Method for producing coated drugs having a stable profile for the release of active ingredients |